Leveraging Transdermal Alcohol Monitoring to Reduce Drinking Among DWI Defendants (NCT03638596) | Clinical Trial Compass
CompletedNot Applicable
Leveraging Transdermal Alcohol Monitoring to Reduce Drinking Among DWI Defendants
United States158 participantsStarted 2017-05-01
Plain-language summary
The current study will evaluate the efficacy of contingency management (i.e., reinforcement for avoiding heavy drinking) among adults arrested for drunk driving and who are at risk for ongoing heavy drinking.
Who can participate
Age range
21 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* arrested for drunk driving offense
Exclusion Criteria:
* significant alcohol withdrawal symptoms
* medical condition that would contraindicate participation (e.g., pregnancy, scheduled surgery)
* inability to comprehend the informed consent process or study instructions
* presence of a DSM-5 psychiatric disorder with symptoms of psychosis and/or delirium
* incarceration
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial used a wearable device to monitor alcohol through the skin in people with DWI charges — is that kind of continuous alcohol monitoring something that could be relevant or helpful for my situation, and how does it compare to other ways of tracking sobriety?
2Since this trial is now completed and was measuring 'percent heavy drinking days,' has my doctor seen the results, and what did they actually show about whether the monitoring device helped people drink less?
3This study focused specifically on DWI defendants — does that mean the approach or findings might not apply to someone in my circumstances, and are there other completed trials with results more relevant to my case?
4Because this was listed as 'Phase NA,' meaning it wasn't a drug trial but more of a behavioral or monitoring intervention, what does my doctor think about how strong the evidence would be compared to, say, a medication-based treatment for alcohol use?
5Are there standard treatment options — like counseling, medication-assisted treatment, or court-mandated programs — that my doctor would recommend I consider alongside or instead of the approach used in this study?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Percent heavy drinking days
Timeframe: 8-weeks
Trial details
NCT IDNCT03638596
SponsorThe University of Texas Health Science Center at San Antonio